How to switch a patient from metoprolol 25 mg twice a day to propranolol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from Metoprolol 25 mg Twice Daily to Propranolol

For a patient on metoprolol 25 mg twice daily (50 mg total daily), switch directly to propranolol 80-120 mg daily in divided doses (40-60 mg twice daily), starting the propranolol the morning after the last metoprolol dose without any overlap or tapering period. 1

Dose Conversion Rationale

The ACC/AHA/ESC guidelines provide clear maintenance dosing for both agents in chronic therapy: metoprolol 25-100 mg twice daily and propranolol 80-240 mg daily in divided doses. 1 Since your patient is on the lowest therapeutic dose of metoprolol (25 mg twice daily = 50 mg total daily), the equivalent starting dose of propranolol should be at the lower end of the therapeutic range.

Recommended Conversion Strategy

  • Start propranolol at 40 mg twice daily (80 mg total daily) as the initial conversion dose for a patient on metoprolol 25 mg twice daily. 1
  • If additional rate control is needed after 3-5 days, increase to 60 mg twice daily (120 mg total daily). 1
  • The maximum dose can reach 240 mg daily in divided doses if clinically indicated. 1

Timing of the Switch

  • Discontinue metoprolol the evening before starting propranolol. 2
  • Begin propranolol the following morning without any washout period or overlap. 2
  • Unlike abrupt cessation without replacement, switching directly to another beta-blocker prevents withdrawal phenomena because continuous beta-blockade is maintained. 2

Why No Tapering is Needed

Research comparing withdrawal phenomena after different beta-blockers demonstrates that switching directly between beta-blockers does not produce the same withdrawal syndrome as complete cessation. 2 The key is maintaining some degree of beta-blockade during the transition. 3 Metoprolol has a relatively short half-life (3-7 hours), so by the next morning, plasma levels are minimal but propranolol provides immediate replacement beta-blockade. 2, 4

Critical Monitoring Parameters

First 48-72 Hours After Switch

  • Check blood pressure and heart rate 2-4 hours after the first propranolol dose to assess for excessive beta-blockade or inadequate rate control. 1
  • Monitor for symptomatic bradycardia (heart rate <60 bpm with dizziness or lightheadedness). 5
  • Assess for hypotension (systolic BP <100 mmHg with symptoms like dizziness or lightheadedness). 5
  • Listen for new or worsening bronchospasm, particularly if any history of reactive airway disease exists. 5

Ongoing Monitoring (First 2 Weeks)

  • Recheck blood pressure and heart rate at 3-5 days and again at 1-2 weeks. 5
  • Target resting heart rate should be 50-60 bpm unless limiting side effects occur. 5
  • Watch for delayed adverse effects like fatigue or weakness, which may appear within 2-3 weeks. 5

Important Contraindications to Verify Before Switching

Both metoprolol and propranolol share the same major contraindications, but you must verify these are not present before making the switch:

  • No signs of decompensated heart failure (new or worsening dyspnea, edema, orthopnea). 1
  • No second or third-degree heart block without a functioning pacemaker. 1
  • No active asthma or severe reactive airway disease. 1
  • Systolic blood pressure >100 mmHg. 5
  • Heart rate >50 bpm. 5

Propranolol-Specific Considerations

Dosing Schedule

  • Propranolol must be given in divided doses (typically twice or three times daily) because it has a shorter half-life than metoprolol succinate extended-release. 1
  • The onset of action is 60-90 minutes for oral propranolol. 1
  • Administer propranolol with or after meals to enhance absorption and reduce risk of hypoglycemia. 1

Pharmacokinetic Differences

  • Propranolol is a non-selective beta-blocker (blocks both β1 and β2 receptors), while metoprolol is β1-selective. 1
  • This means propranolol has greater potential for bronchospasm in patients with any reactive airway component. 1
  • Propranolol also has more CNS penetration and may cause more sleep disturbances or vivid dreams compared to metoprolol. 1

Common Pitfalls to Avoid

  • Never stop metoprolol for several days before starting propranolol, as this creates a gap in beta-blockade and risks withdrawal phenomena including rebound hypertension, tachycardia, and angina exacerbation. 3, 2
  • Do not use a 1:1 mg conversion ratio between metoprolol and propranolol—they are not equipotent on a milligram basis. 1
  • Avoid starting propranolol at the maximum dose of 240 mg daily—begin at 80-120 mg daily and titrate up based on response. 1
  • Do not overlook the need for divided dosing with propranolol—once-daily dosing is inadequate for sustained beta-blockade with immediate-release propranolol. 1, 6

Alternative Approach: Long-Acting Propranolol

If compliance with twice-daily dosing is a concern, consider long-acting propranolol formulation:

  • Long-acting propranolol allows once-daily dosing with sustained beta-blockade over 24 hours. 6
  • The bioavailability is 30-50% less than conventional propranolol, so doses may need to be higher. 6
  • Start at 80 mg once daily of long-acting formulation, equivalent to approximately 40 mg twice daily of immediate-release. 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Metoprolol Treatment Protocol for Hypertension and Heart-Related Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.